AI cancer screening is booming, most not covered by insurance
Artificial intelligence for cancer screening has taken off. Yet most of those new programs aren’t covered by Medicare or private insurers, which creates headwinds for companies looking to boost adoption and for patients who could benefit from the new technology. “Traditionally, for medical devices it takes up to seven years after a product that’s … Read more
